نتایج جستجو برای: pegylation

تعداد نتایج: 824  

Journal: :Langmuir : the ACS journal of surfaces and colloids 2005
Susan M Daly Todd M Przybycien Robert D Tilton

Covalent grafting of poly(ethylene glycol) (PEG) to pharmaceutical proteins, "PEGylation", is becoming more commonplace due to improved therapeutic efficacy. As these conjugates encounter interfaces in manufacture, purification, and end use and adsorption to these interfaces may alter achievable production yields and in vivo efficacies, it is important to understand how PEGylation affects prote...

2011
John W. Lamppa Margaret E. Ackerman Jennifer I. Lai Thomas C. Scanlon Karl E. Griswold

Alginate lyase enzymes represent prospective biotherapeutic agents for treating bacterial infections, particularly in the cystic fibrosis airway. To effectively deimmunize one therapeutic candidate while maintaining high level catalytic proficiency, a combined genetic engineering-PEGylation strategy was implemented. Rationally designed, site-specific PEGylation variants were constructed by orth...

2012
James Mu Jason Pinkstaff Zhihua Li Lillian Skidmore Nina Li Heather Myler Qing Dallas-Yang Anna-Maria Putnam Jun Yao Stuart Bussell Margaret Wu Thea C. Norman Carlos G. Rodriguez Bruce Kimmel Joseph M. Metzger Anthony Manibusan Darin Lee Dennis M. Zaller Bei B. Zhang Richard D. DiMarchi Joel P. Berger Douglas W. Axelrod

Fibroblast growth factor 21 (FGF21) mitigates many of the pathogenic features of type 2 diabetes, despite a short circulating half-life. PEGylation is a proven approach to prolonging the duration of action while enhancing biophysical solubility and stability. However, in the absence of a specific protein PEGylation site, chemical conjugation is inherently heterogeneous and commonly leads to dra...

2012
Zhifeng Huang Guanghui Zhu Chuanchuan Sun Jingui Zhang Yi Zhang Youting Zhang Chaohui Ye Xiaojie Wang Dariush Ilghari Xiaokun Li

Keratinocyte growth factor 1 (KGF-1) has proven useful in the treatment of pathologies associated with dermal adnexae, liver, lung, and the gastrointestinal tract diseases. However, poor stability and short plasma half-life of the protein have restricted its therapeutic applications. While it is possible to improve the stability and extend the circulating half-life of recombinant human KGF-1 (r...

Journal: :Green Chemistry 2021

A family of new bio-based surfactants have been prepared via the epoxidation and PEGylation lactonic sophorolipids. This modification enhances their performance diversifying potential applications.

Journal: :Nano letters 2012
Jillian L Perry Kevin G Reuter Marc P Kai Kevin P Herlihy Stephen W Jones J Chris Luft Mary Napier James E Bear Joseph M DeSimone

In this account, we varied PEGylation density on the surface of hydrogel PRINT nanoparticles and systematically observed the effects on protein adsorption, macrophage uptake, and circulation time. Interestingly, the density of PEGylation necessary to promote a long-circulating particle was dramatically less than what has been previously reported. Overall, our methodology provides a rapid screen...

Journal: :The Korean Journal of Internal Medicine 2018

2012
Nancy Smyth Templeton Neil Senzer

Intravenous injection of therapeutics is required to effectively treat or cure metastatic cancer, certain cardiovascular diseases, and other acquired or inherited diseases. Using this route of delivery allows potential uptake in all disease targets that are accessed by the bloodstream. However, normal tissues and organs also have the potential for uptake of therapeutic agents. Therefore, invest...

2013
Hongjun Gao Jinjian Liu Cuihong Yang Tangjian Cheng Liping Chu Hongyan Xu Aimin Meng Saijun Fan Linqi Shi Jianfeng Liu

Polyethylene glycol (PEG)-ylation is a widely used strategy to fabricate nanocarriers with a long blood circulation time. Further elaboration of the contribution of the surface PEGylation pattern to biodistribution is highly desirable. We fabricated a series of polyion complex (PIC) micelles PEGylated with different ratios (PEG2k and PEG550). The plasma protein adsorption, murine macrophage upt...

2012
Ahmad Abolhasani Sameereh Hashemi-Najafabadi Mahvash Khodabandeh Shahraki

Interferon-beta-1a (IFN-β-1a) is used clinically in the treatment of multiple sclerosis. Similar to other biological molecules, IFN-β-1a has a relatively short serum half-life and is rapidly detected by the host’s immune system. PEGylation is a common approach to increase the blood circulation time of therapeutic proteins. In the present study, IFN-β-1a was PEGylated using linear methoxy polyet...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید